Colon targeting with bacteria-sensitive films adapted to the disease state

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 73, Issue 1, 2009, Pages 74-81

  Karrout, Youness ^a   Neut, Christel ^a   Wils, Daniel ^b   Siepmann, Florence ^a   Deremaux, Laetitia ^b   Dubreuil, Luc ^a   Desreumaux, Pierre ^a   Siepmann, Juergen ^a  

^a UNIV LILLE   (France)

^b Roquette Freres   (France)

Author keywords

Colon targeting; Controlled drug delivery; Ethylcellulose; Film coating; Polysaccharide

Indexed keywords

ETHYL CELLULOSE; PREBIOTIC AGENT; STARCH; WATER;

ADULT; ARTICLE; BACTERIAL COUNT; BACTEROIDES; BIFIDOBACTERIUM; CITROBACTER FREUNDII; CLINICAL ARTICLE; CLOSTRIDIUM; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CROHN DISEASE; CULTURE MEDIUM; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG TARGETING; DRY MASS; ENTERITIS; ENTEROBACTERIACEAE; ENZYME RELEASE; ENZYME SUBSTRATE; ESCHERICHIA COLI; FILM COATING; FUSOBACTERIUM; HUMAN; INTESTINE FLORA; LACTOBACILLUS; PATHOPHYSIOLOGY; PREVOTELLA; SIMULATION; STOMACH CONTENT; STREPTOCOCCUS; ULCERATIVE COLITIS; UPPER GASTROINTESTINAL TRACT; VEILLONELLA; WATER TRANSPORT;

ADULT; ANIMALS; BACTERIA; CATTLE; CELLULOSE; COLITIS, ULCERATIVE; COLON; CROHN DISEASE; DRUG DELIVERY SYSTEMS; HUMANS; MIDDLE AGED; RATS; YOUNG ADULT;

EID: 68349144730     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejpb.2009.04.003     Document Type: Article

References (36)

1. Meissner Y., and Lamprecht A. Alternative drug delivery approaches for the therapy of inflammatory bowel disease. J. Pharm. Sci. 97 (2008) 2878-2891
2. Bondesen S. Intestinal fate of 5-aminosalicylic acid: regional and systemic kinetic studies in relation to inflammatory bowel disease. Pharmacol. Toxicol. 81 Suppl. 2 (1997) 1-28
3. Lamprecht A., Stallmach A., Kawashima Y., and Lehr C.M. Carrier systems for the treatment of inflammatory bowel disease. Drugs Fut. 27 (2002) 961-971
4. Haupt S., and Rubinstein A. The colon as a possible target for orally administered peptides and proteins. Crit. Rev. Ther. Drug Carrier Syst. 19 (2002) 499-545
5. 13C] glucose microspheres as a model for drug delivery to the colon. J. Control. Release 40 (1996) 123-131
6. Milojevic S., Newton J.M., Cummings J.H., Gibson G.R., Botham R.L., Ring S.G., Stockham M., and Allwood M.C. Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets. J. Control. Release 38 (1996) 75-84
7. Milojevic S., Newton J.M., Cummings J.H., Gibson G.R., Botham R.L., Ring S.G., Stockham M., and Allwood M.C. Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using glucose pellets. J. Control. Release 38 (1996) 85-94
8. Yang L., Chu J.S., and Fix J.A. Colon-specific drug delivery: new approaches and in vitro/in vivo evaluation. Int. J. Pharm. 235 (2002) 1-15
9. Leong C.W., Newton J.M., Basit A.W., Podczeck F., Cummings J.H., and Ring S.G. The formation of colonic digestible films of amylose and ethylcellulose from aqueous dispersions at temperatures below 37 °C. Eur. J. Pharm. Biopharm. 54 (2002) 291-297
10. Siew L.F., Man S.M., Basit A.W., and Newton J.M. Amylose formulations for drug delivery to the colon: a comparison of two fermentation models to assess colonic targeting performance in vitro. Int. J. Pharm. 273 (2004) 129-134
11. Siew L.F., Basit A.W., and Newton J.M. The properties of amylose-ethylcellulose films cast from organic-based solvents as potential coatings for colonic drug delivery. Eur. J. Pharm. Sci. 11 (2000) 133-139
12. Gazzaniga A., Iamartino P., Maffione G., and Sangalli M.E. Oral delayed-release system for colonic specific delivery. Int. J. Pharm. 108 (1994) 77-83
13. Gazzaniga A., Sangalli M.E., and Giordano F. Oral chronotropic drug delivery systems: achievement of time and/or site specificity. Eur. J. Pharm. Biopharm. 40 (1994) 246-250
14. Sangalli M.E., Maroni A., Zema L., Busetti C., Giordano F., and Gazzaniga A. In vitro and in vivo evaluation of an oral system for time and/or site-specific drug delivery. J. Control. Release 73 (2001) 103-110
15. Gazzaniga A., Maroni A., Sangalli M.E., and Zema L. Time-controlled oral delivery systems for colon targeting. Expert Opin. Drug Deliv. 3 5 (2006) 583-597
16. McConnell E.L., Short M.D., and Basit A.W. An in vivo comparison of intestinal pH and bacteria as physiological trigger mechanisms for colonic targeting in man. J. Control. Release 130 (2008) 154-160
17. Ibekwe V., Fadda H., David E., and Basit A. A new concept in targeting the colon: a combined pH and bacterial triggered drug delivery technology for improving the treatment of inflammatory bowel diseases. Gastroenterology 134 Suppl. 1 (2008) A673
18. McConnell E.L., Fadda H.M., and Basit A.W. Gut instincts: explorations in intestinal physiology and drug delivery. Int. J. Pharm. 364 (2008) 213-226
19. Sinha V.R., and Kumria R. Microbially triggered drug delivery to the colon. Eur. J. Pharm. Sci. 18 (2003) 3-18
20. Sinha V.R., and Kumria R. Polysaccharides in colon-specific drug delivery. Int. J. Pharm. 224 (2001) 19-38
21. Friend D.R. New oral delivery systems for treatment of inflammatory bowel disease. Adv. Drug Deliv. Rev. 57 (2005) 247-265
22. El Yamani J., Mizon C., Capon C., Colombel J.F., Fournet B., Cortot A., and Mizon J. Decreased fecal exoglycosidase activities identify a subset of patients with active Crohn's Disease. Clin. Sci. 83 (1992) 409-415
23. Carrette O., Favier C., Mizon C., Neut C., Cortot A., Colombel J.F., and Mizon J. Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's Diseases. Digest. Dis. Sci. 40 (1995) 2641-2646
24. Favier C., Neut C., Mizon C., Cortot A., Colombel J.F., and Mizon J. Fecal β-d-galactosidase production and bifidobacteria are decreased in Crohn's Disease. Digest. Dis. Sci. 42 (1997) 817-822
25. Linskens R.K., Huijsdens X.W., Savelkoul P.H., Vandenbroucke-Grauls C.M., Meuwissen S.G., and Scand J. The bacterial flora in inflammatory bowel disease: current insights in pathogenesis and the influence of antibiotics and probiotics. Gastroenterology 234 Suppl. (2001) 29-40
26. Siccardi D., Turner J.R., and Mrsny J. Regulation of intestinal epithelial function: a link between opportunities for macromolecular drug delivery and inflammatory bowel disease. Adv. Drug Deliv. Rev. 57 (2005) 219-235
27. Yilmaz G., Oengen G., Jongboom R.O.J., Feil H., van Dijk C., and Hennink W.E. Modulated release of a volatile compound from starch matrixes via enzymatically controlled degradation. Biomacromolecules 3 (2002) 305-311
28. Yilmaz G., Jongboom R.O.J., Feil H., van Dijk C., and Hennink W.E. Permeation of volatile compounds through starch films. Biomacromolecules 5 (2004) 650-656
29. Wang X., Conway P.L., Brown I.L., and Evans A.J. In vitro utilisation of amylopectin and high-amylose maize (amylomaize) starch granules by human colonic bacteria. Appl. Environ. Microbiol. 65 (1999) 4848-4854
30. Neut C., Bulois P., Desreumaux P., Membré J.M., Lederman E., Gambiez L., Cortot A., Quandalle P., van Kruiningen H., and Colombel J.F. Changes in the bacterial flora of the neoterminal ileum after ileocolonic resection for Crohn's Disease. Am. J. Gastroenterol. 97 (2002) 939-946
31. In: Crank J., and Park G.S. (Eds). Diffusion in Polymers (1968), Academic Press, London
32. Siepmann J., and Peppas N.A. Hydrophylic matrices for controlled drug delivery: an improved mathematical model to predict the resulting drug release kinetics (the "sequential layer" model). Pharm. Res. 17 (2000) 1290-1298
33. In: Fan L.T., and Singh S.K. (Eds). Controlled Release: A Quantitative Treatment (1989), Springer-Verlag, Berlin
34. Lecomte F., Siepmann J., Walther M., MacRae R.J., and Bodmeier R. pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: elucidation of the underlying mass transport mechanisms. Pharm. Res. 22 (2005) 1129-1141
35. Lecomte F., Siepmann J., Walther M., MacRae R.J., and Bodmeier R. Blends of enteric and GIT-insoluble polymers used for film coating: physicochemical characterization and drug release patterns. J. Control. Release 89 (2003) 457-471
36. Lecomte F., Siepmann J., Walther M., MacRae R.J., and Bodmeier R. pH-Sensitive polymer blends used as coating materials to control drug release from spherical beads: importance of the type of core. Biomacromolecules 6 (2005) 2074-2083